Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Ting Liu

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Cancer Communications (London, England)|March 31, 2019
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective studySai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Plos One|April 16, 2015
Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy eraLin Quan Tang, Dong Peng Hu, Qiu Yan Chen, et al.
Oncotarget|December 31, 2015
Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapyLu Zhang, Lin-Quan Tang, Qiu-Yan Chen, et al.
Oncotarget|March 17, 2016
Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysisLu Zhang, Huai Liu, Lin-Quan Tang, et al.
Therapeutic Advances in Medical Oncology|June 16, 2020
Induction chemotherapy followed by radiotherapy <i>versus</i> concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinomaLi-Ting Liu, Yu-Jing Liang, Shan-Shan Guo, et al.
Nature Communications|February 3, 2024
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trialHu Liang, Yao-Fei Jiang, Guo-Ying Liu, et al.
BMC Cancer|December 22, 2018
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinomaSai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialDong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal CarcinomaLi-Ting Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
The Laryngoscope|February 22, 2021
Efficacy of Transnasal Endoscopic Fine-Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal CarcinomaQing-Nan Tang, Lin-Quan Tang, Li-Ting Liu, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Cancer Communications (London, England)|March 31, 2019
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective studySai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Plos One|April 16, 2015
Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy eraLin Quan Tang, Dong Peng Hu, Qiu Yan Chen, et al.
Oncotarget|December 31, 2015
Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapyLu Zhang, Lin-Quan Tang, Qiu-Yan Chen, et al.
Oncotarget|March 17, 2016
Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysisLu Zhang, Huai Liu, Lin-Quan Tang, et al.
Therapeutic Advances in Medical Oncology|June 16, 2020
Induction chemotherapy followed by radiotherapy <i>versus</i> concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinomaLi-Ting Liu, Yu-Jing Liang, Shan-Shan Guo, et al.
Nature Communications|February 3, 2024
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trialHu Liang, Yao-Fei Jiang, Guo-Ying Liu, et al.
BMC Cancer|December 22, 2018
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinomaSai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialDong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal CarcinomaLi-Ting Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
The Laryngoscope|February 22, 2021
Efficacy of Transnasal Endoscopic Fine-Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal CarcinomaQing-Nan Tang, Lin-Quan Tang, Li-Ting Liu, et al.
Pageof 13